US Clinical Trial NCT03982173

A Phase II Whole Exome Secquencing-based Basket Trial for Combination Therapy With Durvalumab (Anti-PDL1) (MEDI4736) and Tremelimumab (Anti-CTLA4) in Patients With Metastatic Solid Tumors  Jun 7, 2019

Parties

Sponsors
Countries
FR
Keywords
Esophageal Adenocarcinoma MATILDA Metastatic Colorectal Cancer Prostate Adenocarcinoma Stomach Adenocarcinoma Triple Negative Breast Cancer

JSON preview

Similar records

Title

Source:  NIH Last updated:  Jun 12, 2019

From ClinicalTrials.gov, a database of the U.S. National Institutes of Health, through its National Library of Medicine. This record may not reflect the most current and accurate biomedical/scientific data available from the NLM/NIH.